FERRLECIT

Ferrlecit is used to treat iron deficiency anemia in patients on chronic hemodialysis who are receiving treatment to stimulate the production of red blood cells.

You should not be given Ferrlecit if you have an anemia that is not related to iron deficiency, or if you have iron overload.

• Immediate allergic reactions to intravenous iron carbohydrate complexes can cause death. Preparation for appropriate resuscitation equipment is recommended.
• Ferrlecit can cause a severe drop in blood pressure together with flushing, lightheadedness, weakness, fatigue, or severe pain in the chest, back or groin. Do not exceed recommended dosage levels. These reactions usually end within one or two hours.

• Iron is not easily eliminated from the body, and its build up can be toxic. Certain medical conditions may make you more likely to develop iron overload. Your doctor will decide if Ferrlecit is right for you.
• Tell your health care provider if you are trying to become pregnant, are already pregnant, or are breast-feeding.
• Ferrlecit contains benzyl alcohol and therefore should not be used in newborns.